We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Why 97% of Oncology Clinical Trials Fail To Receive FDA Approval

Article   Nov 27, 2019 | by Andrew Lynn, Fluidic Analytics

 
Why 97% of Oncology Clinical Trials Fail To Receive FDA Approval
 
 
 

RELATED ARTICLES

Brexit – Liberation or Limitation for the Life Sciences Sector?

Article

We’re now somewhere between the second and third attempt at the UK leaving the EU. Yet, as we approach the turn of the year, the future remains opaque. As with the last two attempts the incumbent government has committed to “absolutely no further delay”, this time past January 31, 2020. But with the general election results only days away this is far from certain – ambiguity and surprise at what unfolds seem to have become normalized states.

READ MORE

Scientists Left Perplexed at Latest Alzheimer’s Drug Data

Article

In this article, we revisit the many twists and turns of the aducanumab clinical trials and explore the scientific community's response to the latest analysis of the data.

READ MORE

What is Pharmacovigilance?

Article

Pharmaceutical drugs are a valuable part of patient care throughout the world. For doctors to adequately care for their patients, drug safety must be monitored and reported from initial testing to everyday use. In this article, we explore the world of pharmacovigilance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE